scholarly article | Q13442814 |
P2093 | author name string | Christopher M Booth | |
D Robert Siemens | |||
P2860 | cites work | Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial | Q33396809 |
Surgeon volume and operative mortality in the United States. | Q34279907 | ||
Muscle-invasive urothelial carcinoma of the bladder | Q36729131 | ||
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. | Q36729145 | ||
Radiotherapy for bladder cancer | Q36729153 | ||
Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system | Q37342899 | ||
Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process | Q37371642 | ||
Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up | Q37489176 | ||
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. | Q37859970 | ||
Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials | Q38135618 | ||
Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: a population-based study | Q39169333 | ||
Surgical factors influence bladder cancer outcomes: a cooperative group report | Q43478885 | ||
Hospital volume and surgical mortality in the United States. | Q44464097 | ||
Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience | Q44829874 | ||
Hospital volume and late survival after cancer surgery | Q44885085 | ||
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder | Q45541917 | ||
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. | Q45967681 | ||
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium | Q79329951 | ||
Processes of care and the impact of surgical volumes on cancer-specific survival: a population-based study in bladder cancer | Q86098826 | ||
Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study | Q87682876 | ||
Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice | Q88052314 | ||
Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study | Q88130966 | ||
P433 | issue | 9-10 | |
P304 | page(s) | E755-7 | |
P577 | publication date | 2014-09-01 | |
P1433 | published in | Canadian Urological Association journal | Q26842808 |
P478 | volume | 8 |